Diabetes Mellitus, Type 1: all 3,614 studies
Page 36 of 37. Open to participants first (586), then studies with results posted, then the rest; newest registration first within each.
- Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study.CompletedNCT00321256Phase 1/2
- Blood Glucose Awareness Training for ParentsCompletedNCT00315991Not applicable
- Study to Estimate the Effects of Inhaled Versus Intravenous (IV) Infusion of Human Insulin in Subjects With Type 1 DiabetesCompletedNCT00315952Phase 4
- Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes MellitusCompletedNCT00315133Phase 1/2
- SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1CompletedNCT00313937Phase 4
- The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting InsulinsCompletedNCT00313742Phase 4
- A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes MellitusCompletedNCT00313183Phase 2
- Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 DiabetesCompletedNCT00312156Phase 3
- Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 DiabetesCompletedNCT00312104Phase 3
- Clinical Islet Transplantation Using the Edmonton ProtocolWithdrawnNCT00309231
- Effects of Nurse-counselling in the Improvement of the type1 Diabetes Control in AdolescentsCompletedNCT00308256Not applicable
- Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free ImmunosuppressionCompletedNCT00306098Phase 2
- A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes MellitusCompletedNCT00304538Phase 1
- Islet Cell Transplants for DiabetesTerminatedNCT00303134Phase 1
- Telemetric Glucose Data Acquisition During Initiation of Insulin Pump TherapyWithdrawnNCT00297635Phase 2
- Insulin Glulisine in Type 1 Diabetes MellitusCompletedNCT00297583Phase 1
- Renal and Peripheral Hemodynamic Function in Patients With Type 1 Diabetes MellitusCompletedNCT00297401Phase 3
- Continuous Subcutaneous Infusion of Pramlintide and InsulinCompletedNCT00291772Phase 4
- Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes MellitusCompletedNCT00290979Phase 3
- Glulisine Pre- and PostmealCompletedNCT00290043Phase 1
- Study to Compare Intraperitoneal Insulin to Subcutaneous Insulin Administration in Type 1 Diabetes MellitusCompletedNCT00286962Phase 3
- Anti-Thymocyte Globulin, Cyclosporine, and RAD in Islet TransplantationCompletedNCT00286624Phase 1/2
- Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 DiabetesCompletedNCT00285233Phase 1/2
- Metabolic Effects of Accurate Blood Sugar Results and Education in Type 1 DiabetesCompletedNCT00284232Phase 4
- A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.CompletedNCT00283218Not applicable
- TEDDY - The Environmental Determinants of Diabetes in the YoungCompletedNCT00279318
- Effect of C-Peptide on Diabetic Peripheral NeuropathyCompletedNCT00278980Phase 2
- Treatment Trial Evaluating Long Acting Insulin in Type 1 DiabetesCompletedNCT00276393Phase 4
- Family Management of Type 1 Diabetes in ChildrenCompletedNCT00273286Phase 2
- Insulin Glargine in Type 1 Diabetes MellitusCompletedNCT00272090Phase 3
- Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic PatientsCompletedNCT00271284Phase 3
- Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic RecipientsTerminatedNCT00260234Phase 1/2
- A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1CompletedNCT00239148Phase 1
- Vascular Reactivity in Kidney Disease PatientsCompletedNCT00226902Not applicable
- Intranasal Insulin for Prevention of Type 1 DiabetesStatus unknownNCT00223613Phase 3
- Islet Transplantation in Type 1 Diabetic PatientsCompletedNCT00214253Phase 1
- A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes MellitusWithdrawnNCT00214214Phase 1
- Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin TreatmentCompletedNCT00213109Phase 3
- T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes MellitusCompletedNCT00212329
- Lantus in the Treatment of Type 1 Diabetes ChildrenCompletedNCT00206401Phase 4
- Ability to Cope With Type 1 DiabetesCompletedNCT00206362
- Ability to Cope With Type 1 DiabetesCompletedNCT00206349
- The Effect of Prolonged Pramlintide Infusion in Pediatric DiabetesCompletedNCT00206297Phase 3
- The Role of Amylin and Glucagon in T1DMCompletedNCT00206258Phase 3
- Outcomes and Cost Consequences of Using an Internet Co-Management Module to Improve the Quality of Type 1 Diabetes CareCompletedNCT00194558Not applicable
- Local Registration Trial in China Humalog Mix 50CompletedNCT00191581Phase 3
- Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 DiabetesStatus unknownNCT00190502Not applicable
- Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes MellitusCompletedNCT00187564Not applicable
- Ischemic Injury and Ischemic Preconditioning in DiabetesCompletedNCT00184821
- Comparison of Insulin Detemir With NPH Insulin in Type 1 DiabetesCompletedNCT00184665Phase 3
- Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 DiabetesCompletedNCT00184639Phase 3
- Islet Transplantation Using Campath-1H and Infliximab InductionCompletedNCT00175266Phase 2
- Alemtuzumab Induction in Islet TransplantationCompletedNCT00175253Phase 2
- The Role of Regulatory T Cell in Patients With Type 1 Diabetes MellitusStatus unknownNCT00173641
- Autoantibodies in Patients With Type 1 Diabetes MellitusStatus unknownNCT00173628
- Pilot Study of the Navigator Continuous Glucose MonitorCompletedNCT00166673Phase 2/3
- Allogenic Islet Cell TransplantationActive, not recruitingNCT00160732Phase 1/2
- Type 1 Diabetes Aerobic and Resistance Exercise (T1-DARE)CompletedNCT00148538Phase 3
- The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I DiabetesCompletedNCT00147342
- A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 DiabetesCompletedNCT00146484Phase 2
- The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes MellitusCompletedNCT00145379Phase 4
- Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin DoseStatus unknownNCT00145353Phase 4
- Renin Angiotensin System Study (RASS/B-RASS)CompletedNCT00143949Phase 2
- To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.CompletedNCT00143104Phase 2
- Feasibility Study of 2000 IU Per Day of Vitamin D for the Primary Prevention of Type 1 DiabetesCompletedNCT00141986Phase 1
- European Trial of Immunosuppression in SPK TxCompletedNCT00140543Phase 3
- Influence of Binge Drinking on Glucose Metabolism in Patients With Type 1 Diabetes - A Pilot StudyCompletedNCT00135915
- Efficacy of Diazoxide in Type 1 DiabetesCompletedNCT00131755Phase 4
- Pediatric Atorvastatin in Diabetes Intervention Trial (PADIT)CompletedNCT00130481Not applicable
- Study of Human Insulin Inhalation Powder in Patients With Type 1 DiabetesCompletedNCT00127634Phase 3
- Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney DiseaseCompletedNCT00118976Not applicable
- Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and DietCompletedNCT00118937Phase 4
- Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 DiabetesCompletedNCT00117780Phase 4
- Effects of Vitamin B1 in Type 1 Diabetic PatientsCompletedNCT00117026Phase 1/2
- Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and AdolescentsCompletedNCT00115570Phase 3
- Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 DiabetesCompletedNCT00109434
- Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes MellitusCompletedNCT00108004Phase 3
- Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes MellitusCompletedNCT00107107Phase 3
- Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical TrialsCompletedNCT00105352Not applicable
- Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and AdolescentsCompletedNCT00097071Phase 3
- NovoLog Observation Trial in Subjects With Type 1 and Type 2 DiabetesCompletedNCT00095446Phase 4
- Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 DiabetesCompletedNCT00095082Phase 3
- Islet Transplantation for Patients With Type 1 DiabetesCompletedNCT00073281Phase 1
- Safety and Pharmacokinetics (PK) of hOKT3g1 (Ala-Ala) in Type 1 Diabetes Mellitus (T1DM)CompletedNCT00073255Phase 1
- Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric PopulationCompletedNCT00071448Phase 3
- Safety and Efficacy of INGAP-Peptide in Patients With Type 1 DiabetesCompletedNCT00071409Phase 2
- Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch BiographerCompletedNCT00069628Phase 4
- Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in ChildrenCompletedNCT00069615Phase 4
- Continuous Glucose Monitors for Children With Diabetes MellitusCompletedNCT00069537Phase 4
- Matrix Metalloproteinases and Diabetic NephropathyCompletedNCT00067886
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I DiabetesCompletedNCT00064714Phase 2
- Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus.CompletedNCT00063128Phase 2
- Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)TerminatedNCT00058981Phase 2
- Evaluation of a Diabetes Vaccine in Newly Diagnosed DiabeticsCompletedNCT00057499Phase 1
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044408Phase 3
- Treatment for Symptomatic Peripheral Neuropathy in Patients With DiabetesCompletedNCT00044395Phase 3
- Evaluation of the Effect of Pramlintide on Satiety and Food IntakeCompletedNCT00042601Phase 2
- Evaluation of the Bioavailability of PramlintideCompletedNCT00042471Phase 2
- Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose ControlCompletedNCT00042458Phase 3
- Risk Factors for Atherogenesis in Type 1 DiabetesCompletedNCT00035750